Reference
Pikman Y, et al. Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma. Blood Advances 4: 1265-1269, No. 7, 14 Apr 2020. Available from: URL: http://doi.org/10.1182/bloodadvances.2019001256
Rights and permissions
About this article
Cite this article
Antineoplastics/immunosuppressants. Reactions Weekly 1805, 42 (2020). https://doi.org/10.1007/s40278-020-78752-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-78752-8